Edition:
United States

People: Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

78.64EUR
29 Mar 2017
Change (% chg)

-- (--)
Prev Close
€78.64
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
663,727
52-wk High
€85.65
52-wk Low
€70.00

Lipps, Ben 

Dr. Ben J. Lipps is Honorary Chairman of Fresenius Medical Care AG & Co KGaA since January 1, 2013. After earning his Master and Doctoral degrees at the Massachusetts Institute of Technology in Chemical Engineering, Dr. Lipps led the research team that developed the first commercial Hollow Fiber Artificial Kidney at the end of the 1960s at DOW Chemical. Dr. Lipps has held the position of Chairman of the Management Board of Fresenius Medical Care Holdings Inc., USA and Member of the Management Board of Fresenius Management SE. He has also acted as Member of the Board of Vifor Fresenius Medical Care Renal Pharma Ltd.

Basic Compensation

Total Annual Compensation, EUR 1,172,000
Restricted Stock Awards, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 3,690,000
Fiscal Year Total, EUR 4,862,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gerd Krick

378,000

Rice Powell

5,226,000

Ben Lipps

4,862,000

Dieter Schenk

207,000

Michael Brosnan

3,616,000

Oliver Maier

--
As Of  30 Dec 2015